Development of a versatile lab-on-a-cartridge platform for rapid, multiplexed detection of pathogens like SARS-CoV-2 and Influenza, as well as contaminants in food. This innovative technology aims to enhance public health monitoring and ensure food safety through scalable and cost-effective diagnostics.

Sensor chip production for a molecular recognition platform in medical diagnostics in general and for SARS-CoV-2 diagnostics (both antibody and viral genetic material testing) in particular.

Novus Dx’s SepTec technology, developed with the Microfluidics Innovation Hub, revolutionizes sepsis diagnostics by providing rapid and accurate pathogen detection directly from whole blood in just 15 minutes. This near-patient system combines advanced microfluidic and electrochemical technologies to improve patient outcomes through faster, more reliable sepsis diagnosis.

ViroGates, an international in vitro diagnostics company based in Denmark, is renowned for its innovative solutions in emergency medicine. Their suPARnostic® product line, used extensively in emergency departments, enhances clinical decisions regarding the hospitalization or discharge of acute medical patients.

Hycult Biotech, together with the Microfluidics Innovation Hub, is developing a rapid, non-invasive multiplex assay for detecting complement activation markers in chronic kidney disease. This advanced microfluidic platform aims to improve early diagnosis and monitoring, offering a reliable alternative to invasive kidney biopsies

MEPROlife's SpermSort technology revolutionizes sperm selection for assisted reproduction by combining advanced microfluidics with precise molecular diagnostics, significantly increasing pregnancy rates and improving IVF outcomes.